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Abstrat
As ell proliferation is limited due to the loss of telomere repeats in DNA
of normal somati ells during division, telomere attrition an possibly play an
important role in determining the maximum life span of an organism. With
omputer simulations of ell ulture development in organisms, whih onsist
of tissues of normal somati ells with nite growth, we otain an inrease of
life span for longer telomeri DNA in the zygote. By additionally onsidering
a two-mutation model for arinogenesis and indenite proliferation by the
ativation of telomerase, we demonstrate that the risk of dying due to aner
an outweigh the positive eet of longer telomeres on the longevity.
Keywords: Biologial Ageing; Computer simulations; Telomeres; Telomerase; Can-
er
1 Introdution
Telomeres are tandem repeated nonoding sequenes of nuleotides at both ends of
the DNA in eukaryoti hromosomes stabilizing the hromosome ends and prevent-
ing them from end-to-end fusion or degradation [1℄. Polymerase annot ompletely
repliate the 3' end of linear DNA, so telomeres are shortened at eah DNA replia-
tion [2℄. This end repliation problem leads to a nite repliative apaity for normal
somati ells [3℄. They an only divide up to a ertain threshold, the Hayik limit
[4℄. The enzyme telomerase, repressed in most normal somati ells, synthesizes and
elongates telomere repeat sequenes at the end of DNA strands so that ertain ells
like germline ells are immortal and indenite in growth [5, 6℄.
Most forms of aner follow from the aumulation of somati mutations [7℄.
Caner-derived ell lines and 85-90% of primary human aners are able to synthesize
high levels of telomerase and thus are able to prevent further shortening of their
telomeres and proliferate indenitely [8℄. But if ells are premalignant or already
anerous and telomerase is not yet ativated, the proliferation of these ells and
the aumulation of mutations is determined by their further repliative apaity
[9℄. So the frequeny of malignant aner should be higher for longer telomeres.
Reently published data show that longer telomeri DNA inreased the life span
of nematode worms [10℄. So there may be a positive eet on the longevity of
omplex loned organisms with renewing tissues if the telomere length in zygote
ells is inreased [11℄. As the probability for the inidene of aner is orrelated
with the repliative potential of the mutated ells [12℄, one an ask the following
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question: Is an extension of lifespan of loned organisms possible if telomeres in
embryoni ells are elongated and aner is onsidered? An answer to this question
ould be given by omputer simulations as the presented model fouses on ageing
by the loss of telomeres in DNA.
After presenting the basi model of telomere attrition in organisms and omputa-
tion results, we explain how aner and telomerase are introdued and disuss the
eets of dierent initial telomere lengths.
2 Basi model of biologial ageing due to telomere
shortening
As shortening of telomeres is one of the supposed mehanisms of ageing on ellular
level, there are many dierent approahes to model telomere loss [13, 14, 15, 16℄. In
our basi model every organism is developed from a single progenitor ell, the zygote
(gure 1). The initial telomere length of zygote ells is assumed to be normally
distributed with mean µz and standard deviation σz [17℄. Telomere repeats lost per
division (TRLPD) are randomly hosen at eah division of every ell from a normal
distribution with mean µTRLPD and standard deviation σTRLPD. A dividing ell
produes a lone who inherits the repliative apaity of the progenitor ell at this
age. All normally distributed variables are generated with the Box-Muller method
[18℄. Cells an divide until nearly all their original telomeres are lost.
For every organism the dynamis of the model is as follows: Divisions of the
zygote and the stem ells derived from it our 6 times in the early embryo. Eah of
these ells is the progenitor of one tissue. This is followed by a period of population
doublings where all ells divide one in every timestep until 27 ells are present in
eah tissue. In the following maturation stage, ells are hosen randomly for division
until eah tissue reahes the adult size of 104 ells. It takes about 26 timesteps until
an organism is mature.
Ageing starts now, ells rst die with 10% probability due to events like nerosis
or apoptosis. 10% of the ells of the orresponding tissue are then randomly hosen
for division to ll this gap. The replaement does not have to be omplete as the
hosen ell ould probably not divide anymore due to telomere attrition. After some
time the tissue will start shrinking. The random hoie of dying and dividing ells in
dierentiated tissues is in aordane with nature as for example in epithelium the
hoie of ells to be exported from the basal layer is random [19, 20℄. The organism
dies, if its atual size reahes 50% of its mature size.
2.1 Results without aner
Age distributions for dierent mean telomere lengths in the zygote ells are shown
(gure 2). The shape of these distributions is very analogous to empirial data
of many human and animal populations. We also obtain a positive eet on the
longevity of the organisms if the mean telomere length in the preursor ell is in-
reased.
The hosen mean doubling potentials for primary ells are 30, 40 and 50 with the
hoie of µz = 1500, 2000, 2500 and µTRLPD = 50. The number of mitoti divisions
2
Figure 1: Dynamis of ell proliferation in one organism in the basi model
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Figure 2: Age distribution of 32000 organisms with telomere lengths of µz =
1500(+), µz = 2000(×) and µz = 2500(∗); σz = 100, µTRLPD = 50, σTRLPD = 10
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observed in human broblasts is higher [21℄, but the hoie of this parameters is
reasonable as the number of onsidered ells per mature organism (640000) in this
model is also muh lower than in human organisms where the total number of ells
is of the order of 1013 [19℄.
3 Introduing arinogenesis and telomerase
Clonal aner is now introdued in the model. In aordane to the model of Mool-
gavkar et al., one of our assumptions is that malignant tumors arise from indepen-
dently mutated progenitor ells [22℄. For most forms of arinoma, transformation
of a suseptible stem ell into a aner ell is suggested to be a multistage proess
of suessive mutations with a relatively low probability for the sequential stages
[7, 23℄. Two independent and irreversible hereditary mutation stages are onsidered
here, whih an our at every level of development of the organism during ell
division.
The rst premalignant stage is a promotion: A dividing ell an mutate with small
probability pmut [19℄. All desendant ells inherit this mutation. This mutation leads
to a partial esape from homeostati ontrol of growth by the loal ellular environ-
ment [9, 24℄. Cells on the promotion stage have a seletive advantage over unaeted
ells [25℄. In our model they are hosen rst for division during maturation and for
lling up the gap in the ageing period.
The subsequent transition an our again with probability pmut during division.
If a ell reahes this seond stage of mutation it is a progenitor of a arinoma. An
explosive lonal expansion to a fully malignant ompartment happens [24℄. This ell
and the lonal progeny doubles in the urrent timestep until it is no more possible
due to telomere attrition. This expansion leads only to an inrease of the malignant
ell population size. As a ertain fration of ells is killed per unit time and lonal
expansions only our with a very small probability, the tumor enviroments may not
ontinue growing, eventually shrink, or even die [26℄. We assume that it is neessary
for advaned aner progression and therefore for the development of a deadly tumor
that fully mutated ells are able to ativate telomerase [27℄.
In our model, telomerase ativation is possible at every age of the organism in
normal and mutated ells during division with a very low probability ptelo. The
irreversible loss of repliative potential is stopped in these ells. As the ontribution
of telomerase to tumorigeniity is not yet ompletely understood, [28, 29, 30℄, we
assume that death of an organism due to aner ours if telomerase is reatived in
at least one fully mutated ell [31℄. We treat the time interval between the ourene
of a deadly tumor and death due to it as onstant, so we set this interval to zero. In
our arinogeni proess there are two ways to reah the ritial stage of indenite
proliferation of immortal anerous ells:
1. Telomerase is already reativated in a ell whih reahes the seond mutation
stage.
2. Ativation of telomerase ours in one fully mutated ell during the explosive
lonal expansion of anerous ells after a ell has reahed the seond stage of
mutation.
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3.1 Eets of dierent telomere lengths onsidering aner
Figure 3 shows simulation results for µz = 1500 and µz = 2500. As we onsidered
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Figure 3: Age distribution of 32000 organisms with telomere lengths of µz = 1500
with (∗) and without aner (+) and µz = 2500 with (✷) and without aner
(×); σz = 100, µTRLPD = 50, σTRLPD = 10. Caner mutations are possible with
pmut = 5 ∗ 10
−5
. Telomerase an be ativated with ptelo = 10
−5
.
a lower omplexity by hosing a lower number of tissues and ells per organism, we
assumed higher mutation rates for the inidene of aner than observed in nature
[32, 33℄.
The age distribution for shorter initial telomere lengths onsidering aner is
shifted to the left but still very old organisms exist. Caner inreases only the prob-
ability to die in a ertain range of age whih varies for dierent telomere lengths. For
longer telomeres the age distribution is again shifted to the left but even behind the
distributions for shorter telomeres with and without onsidering aner. There is a
strong inrease in the risk of dying beause of aner and hene the life expetation
is muh lower than for shorter initial telomeres.
The fore of mortality resulting from this model is shown for µz = 1500 with
and without onsidering aner in omparison to empirial human mortality data
(gure 4). It agrees very well with human mortality funtions provided aner is
inorporated into the model, and shows a mortality deeleration at advaned age,
4 Conlusion
The expeted simulation result of the basi model without aner is an inrease of
life span of most organisms with longer initial telomeres. After introduing somati
mutations promoting aner and telomerase ativation in this model, the survival
probability is lower for eah onsidered initial telomere length in ertain time inter-
vals in adult ages.
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Figure 4: Mortality funtion for µz = 1500 with (×) and without aner (+), 32000
organisms onsidered, σz = 100, µTRLPD = 50, σTRLPD = 10; German men (∗) from
www.destatis.de (June 2004) (Sterbetafel 2000/2002)
But even low probabilities for the two mutation stages and for the ativation of
telomerase lead to a strong redution of life span for longer telomeres. So the impli-
ation of two-stage arinogenesis for the inidene of aner in this simple model
of ell proliferation in organisms is that the life span of omplex loned organisms
annot be inreased by artiially elongating telomeres in primary ells.
Further improvements, extentions and appliations of this model are possible.
With respet to the role of telomeres and telomerase in arinogenesis, maybe this
omputational approah an ontribute to the development of a omprehensive the-
oretial model in onology uniting mutagenesis and ell proliferation [34℄.
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